Compare PMEC & POM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PMEC | POM |
|---|---|---|
| Founded | 1984 | 2015 |
| Country | Singapore | China |
| Employees | N/A | N/A |
| Industry | | Other Specialty Stores |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.4M | 38.8M |
| IPO Year | 2023 | 2025 |
| Metric | PMEC | POM |
|---|---|---|
| Price | $0.97 | $0.30 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 20.6K | ★ 1.1M |
| Earning Date | 01-01-0001 | 12-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $74,349,000.00 | $51,210,721.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 2.52 | ★ 12.13 |
| 52 Week Low | $0.56 | $0.26 |
| 52 Week High | $2.44 | $6.43 |
| Indicator | PMEC | POM |
|---|---|---|
| Relative Strength Index (RSI) | 43.26 | N/A |
| Support Level | $0.93 | N/A |
| Resistance Level | $1.16 | N/A |
| Average True Range (ATR) | 0.09 | 0.00 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 26.89 | 0.00 |
Primech Holdings Ltd is a technology-driven facilities services provider in the public and private sectors operating mainly in Singapore. The services offered by the company include Facilities services, Stewarding services, Cleaning services to offices, Cleaning services to homes, and Cleaning Supplies.
Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of revenue is derived from the Pharmaceutical supply chain segment.